A phase II clinical trial of KNP2002 ointment in patients with common warts

Phase 2

Recruiting

• Conditions: Common warts

• Registration Number: JPRN-jRCT2031230115
• Lead Sponsor: Sato Katsuhiko

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-06-07
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1. Subjects aged 15 to 49 at the time of obtaining consent
2. Subjects with typical common warts on the upper extremities or lower extremities excluding the soles of the feet.
3. Subjects who agree to contraception from obtaining consent to 4 weeks after the end of administration
4. Subjects who have given their voluntary written consent to participate in this clinical trial

Exclusion Criteria

1. Subjects with 5 or more warts due to human papillomavirus (HPV) infection on the upper or lower limbs
2. Subjects who are scheduled to undergo treatment such as physical therapy or chemotherapy for warts
3. Subjects with a history of allergy to topical skin preparations
4. Subjects with a history of malignant tumor within 5 years before administration of study drug
5. Subjects with any of the following diseases
Malignant tumor
Serious heart disease
Poorly controlled diabetes, hypertension
6. Women who are pregnant, may become pregnant, or are breastfeeding.

Study & Design

• Study Type: Interventional
• Study Design: Not specified